Work

Proinflammatory and Prothrombotic Effects of Hypoglycemia

Year: 2010
Type: editorial
Abstract: Hypoglycemia is known to be intrinsic to the treatment of diabetes because insulin is a powerful glucoselowering agent and sulfonylureas exert their effect through insulin release by the pancreatic �-cells. Hypoglycemia occurs in association with these two common modes of therapy and was previously accepted as a part of the treatment of this condition. With the arrival of other modes of diabetes treatment, such as metformin, thiazolidenediones, �2glucosidase inhibitors, and incretins, which do not induce hypoglycemia except when administered in combination with insulin and sulfonylureas, the issue of hypoglycemia has to be assessed in the context of both the immediate risk related to neuroglycopenia and the possible long-term risk of diabetic vascular complications. Vascular complications of hypoglycemia have to be tackled with greater urgency now because two recent trials of intensified diabetes treatment with insulin, the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial and Veteran’s
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W2115968076
Cites: 17
Cited by: 83
Related to: 8